University of Cambridge
Investigational Cancer Drug Deemed Highly Mutagenic in Cell Line Sequencing Study
Using whole-genome sequencing on drug-exposed cell lines, researchers saw high mutation rates in control cell lines intermittently treated with a compound called CX-5461.
ASHG: Exome-Wide Association Study Reveals Rare Variants Linked to Severe Adult-Onset Obesity
Led by University of Cambridge researchers, the study analyzed whole-exome data from existing population studies, including the UK Biobank.
A Cambridge University study found phrases touting the benefits of genomics research without acknowledging limitations can turn off the very people researchers need to engage most.
Breast Cancer Risk Genes Unearthed in Exome Sequence Meta-Analysis
Researchers tracked down a handful of previously unappreciated susceptibility genes using exome sequences for more than 244,000 European women with or without breast cancer.
Screening Study IDs Functions for Conserved Proteins in 'Unknome' Collection
Investigators used RNAi screening and CRISPR editing validation testing in fruit flies to untangle functional contributions for conserved proteins with unknown functions.